Thymosin alpha 1 therapy alleviates organ dysfunction of sepsis patients: a retrospective cohort study by Fei Pei, Yishan Liu, Lingyun Zuo, Bin Gu, Liqun Liang, Luhao Wang, Yao Nie, Minying Chen, Xiangdong Guan, Jianfeng Wu, on behalf of the China Critical Care Immunotherapy Research Group

Get full text

Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression by Fei Pei, Ren-Qi Yao, Chao Ren, Soheyl Bahrami, Timothy R. Billiar, Irshad H. Chaudry, De-Chang Chen, Xu-Lin Chen, Na Cui, Xiang-Ming Fang, Yan Kang, Wei-Qin Li, Wen-Xiong Li, Hua-Ping Liang, Hong-Yuan Lin, Ke-Xuan Liu, Ben Lu, Zhong-Qiu Lu, Marc Maegele, Tian-Qing Peng, You Shang, Lei Su, Bing-Wei Sun, Chang-Song Wang, Jian Wang, Jiang-Huai Wang, Ping Wang, Jian-Feng Xie, Li-Xin Xie, Li-Na Zhang, Basilia Zingarelli, Xiang-Dong Guan, Jian-Feng Wu, Yong-Ming Yao, the Shock and Sepsis Society of Chinese Research Hospital Association, the China Critical Care Immunotherapy Research Group, the International Federation of the Shock Societies (IFSS)

Get full text